GENETIC CONTROL OF CANDIDA ALBICANS BIOFILM DEVELOPMENT
By Jonathan S. Finkel, A. Mitchell. Nature Reviews Microbiology, 2010
648 citations recorded by the source corpus.
Candida species cause frequent infections owing to their ability to form biofilms — surface-associated microbial communities — primarily on implanted medical devices. Increasingly, mechanistic studies have identified the gene products that participate directly in the development of Candida albicans biofilms, as well as the regulatory circuitry and networks that control their expression and activity. These studies have uncovered new mechanisms and signals that govern C. albicans biofilm development and associated drug resistance, thus providing biological insight and therapeutic foresight.
Subfields: Epidemiology, Food Science, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/dde321776d8177c9a6a0bd93de156ef9dc98f523
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Fusco-Almeida
- T. Bernardi
- J. C. O. Sardi
- M. J. Giannini
- L. Scorzoni
Citations in the corpus
- Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “…by IP: 54.70.40.11 On: Sun, 06 Jan 2019 22:21:33 Genetic analyses indicate that both yeast cells and hyphae are crucial for biofilm formation, which suggests that each cell type has a unique role in the process (Finkel & Mitchell, 2011; Al-Fattani & Douglas, 2006; Douglas, 2003).”